热门资讯> 正文
Prenetics收入增长,提升2026年前景
2026-06-10 22:39
- Prenetics Global (PRE) on Wednesday reported first-quarter revenue of $36M and raised its 2026 IM8 revenue forecast to $190M-$210M from $180M-$200M, citing strong demand for its health supplements brand.
- The company said IM8 revenue rose 23% sequentially to $33.8M in the reported quarter and reached a record $16.7M in May, implying about $200M in annualized recurring revenue. It expects second-quarter revenue of $46M-$48M.
- The company reported a $23.1M loss for the reported quarter.
- Prenetics also said it fully exited its digital asset holdings for $41.3M, ended March debt-free with $56M in cash, and appointed supplements industry veteran Brian Rosin as CFO of IM8.
- The company plans to launch new hydration, creatine, and kids' gummies products in the fourth quarter.
- Stock down -8%
More on Prenetics Global
- Prenetics Global: Quarterly Subscription Focus Could Turn $120M AAR Into A Billion-Dollar Machine
- Prenetics Global: On Course To Hit Profitability Amid Globalization Drive
- Prenetics Global reports Q1 results; gives Q2 and raises FY26 outlook
- Seeking Alpha’s Quant Rating on Prenetics Global
- Historical earnings data for Prenetics Global
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。